Tomocube

About:

Tomocube is an innovative startup providing 3D holographic microscopy for scientists and clinicians.

Website: http://www.tomocube.com/

Twitter/X: tomocubeinc

Top Investors: SBVA, InterVest Co., Company K Partners, STIC Ventures, Timepolio Asset Management

Description:

Tomocube’s is dedicated to delivering products that can enhance biological and medical research via novel optical solutions that can assist Tomocube in understanding, diagnosing, and treating human diseases. Current optical microscopes only provide users with a 2D view of their sample. To get a 3D view, users must use expensive and invasive electron or confocal microscopes, which require extensive pre-preparation of samples and are not amenable to dynamic samples such as live cells. Their platform enables researchers to measure nanoscale, real-time, dynamic images of individual living cells without the need for sample preparation.

Total Funding Amount:

26.2B KRW

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Daejeon, Taejon-jikhalsi, South Korea

Founded Date:

2015-08-27

Contact Email:

info(AT)tomocube.com

Founders:

KiHyun Hong

Number of Employees:

11-50

Last Funding Date:

2021-09-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai